S&CO Inc. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 94,310 shares of the exchange traded fund’s stock, valued at approximately $14,924,000.
Other hedge funds have also modified their holdings of the company. Axiom Investment Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $26,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $27,000. Financial Life Planners acquired a new position in SPDR S&P Biotech ETF during the 1st quarter worth approximately $27,000. Intesa Sanpaolo Wealth Management acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $30,000. Finally, SHP Wealth Management bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $31,000.
SPDR S&P Biotech ETF Stock Up 0.4%
NYSEARCA XBI opened at $157.41 on Friday. SPDR S&P Biotech ETF has a 12-month low of $88.18 and a 12-month high of $165.71. The company has a market capitalization of $10.28 billion, a PE ratio of 11.47 and a beta of 0.83. The firm’s 50 day moving average is $150.73 and its 200-day moving average is $136.40.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
